Wire Stories

Category Added in a WPeMatico Campaign

DaiichiSankyo-logo-1

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

Recommendation based on DESTINY-Breast03 trial results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced the risk of disease progression or...

logo-39

Global E-Pharmacy Market Size & Share to 2027 – Featuring Pharmacy2U, Gordons Direct and MedPlus Health Services Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global E-Pharmacy Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering. E-pharmacy is referred...